I specialize in thoracic oncology, with a background in translational research in metastasis, as well as extensive experience in clinical practice in both academic and community settings. My research interests focus on development of clinical trials and translational studies to test novel agents and combinations with immune checkpoint inhibitors for both small cell and non-small cell lung tumors. My clinical focus has been to build a small cell lung cancer program at Yale with a comprehensive portfolio of clinical trials testing novel therapeutics for patients as well for patients with non-small cell lung cancer and thoracic malignancies.
In addition, I am the Deputy Chief Medical Officer and Chief Network Officer for Smilow Cancer Hospital (SCH). I have helped to build our SCH Network and oversee operations, quality efforts and clinical research in our Smilow Care Centers. I have a particular focus in quality measurement and improvement and have worked to achieve ASCO QOPI Certification for the entire Smilow clinical practice. I have spearheaded quality initiatives locally and nationally for ASCO. I am dedicated to quality improvement for patient-centered cancer services, and champion the use of patient-reported outcomes.